Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan + tetracycline dual therapy regimens for Helicobacter pylori eradication
ChiCTR2500101343Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of vonoprazan and tetracycline in Helicobacter pylori infection (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Helicobacter pylori eradication rate. Started Apr 2025; status: recruiting.
02
Drugs
vonoprazantetracycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2500101343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101343.